Daniel Portsmouth

642 total citations
20 papers, 364 citations indexed

About

Daniel Portsmouth is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Daniel Portsmouth has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Infectious Diseases and 3 papers in Agronomy and Crop Science. Recurrent topics in Daniel Portsmouth's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Daniel Portsmouth is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Daniel Portsmouth collaborates with scholars based in Austria, United States and Australia. Daniel Portsmouth's co-authors include Perry Barrett, Hartmut J. Ehrlich, Thomas R. Kreil, Otfried Kistner, Gerald Aichinger, Helga Savidis-Dacho, Brian A. Crowe, Michael G. Schwendinger, M. Keith Howard and Richard Fritz and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Daniel Portsmouth

20 papers receiving 345 citations

Peers

Daniel Portsmouth
Abi George Aleyas South Korea
Karen M. van der Meulen Belgium
Maurício A. Martins United States
Brian E. Dawes United States
Huiyong Wei United States
Souichi Yamada Japan
Kenn Forberg United States
Jianhua Le United States
Marina Escalera‐Zamudio Mexico
Drishya Kurup United States
Abi George Aleyas South Korea
Daniel Portsmouth
Citations per year, relative to Daniel Portsmouth Daniel Portsmouth (= 1×) peers Abi George Aleyas

Countries citing papers authored by Daniel Portsmouth

Since Specialization
Citations

This map shows the geographic impact of Daniel Portsmouth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Portsmouth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Portsmouth more than expected).

Fields of papers citing papers by Daniel Portsmouth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Portsmouth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Portsmouth. The network helps show where Daniel Portsmouth may publish in the future.

Co-authorship network of co-authors of Daniel Portsmouth

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Portsmouth. A scholar is included among the top collaborators of Daniel Portsmouth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Portsmouth. Daniel Portsmouth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwendinger, Michael G., Helga Savidis-Dacho, Brian A. Crowe, et al.. (2015). Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs. PLoS ONE. 10(2). e0113963–e0113963. 18 indexed citations
2.
Fritz, Richard, Klaus K. Orlinger, Stefan Kiermayr, et al.. (2015). Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines. Journal of Virology. 90(4). 1964–1972. 15 indexed citations
3.
Wressnigg, Nina, Perry Barrett, Daniel Portsmouth, et al.. (2014). A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato. Clinical and Vaccine Immunology. 21(11). 1490–1499. 32 indexed citations
4.
Aichinger, Gerald, Barbara Grohmann-Izay, Sandor Fritsch, et al.. (2014). Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults. Clinical and Vaccine Immunology. 22(1). 46–55. 7 indexed citations
5.
6.
Savidis-Dacho, Helga, Daniel Portsmouth, Thomas R. Kreil, et al.. (2014). MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses. PLoS ONE. 9(2). e88340–e88340. 57 indexed citations
7.
Wressnigg, Nina, Daniel Portsmouth, Wolfgang Draxler, et al.. (2014). An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial. Clinical and Vaccine Immunology. 22(3). 267–273. 27 indexed citations
8.
Portsmouth, Daniel, Richard Fritz, Brian A. Crowe, et al.. (2014). Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients. Clinical and Vaccine Immunology. 21(6). 867–876. 11 indexed citations
9.
Fritz, Richard, Christine Hohenadl, Gerald Aichinger, et al.. (2014). Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients. Open Forum Infectious Diseases. 1(2). ofu072–ofu072. 3 indexed citations
10.
Barrett, Perry, Daniel Portsmouth, & Hartmut J. Ehrlich. (2013). Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development. Expert Review of Vaccines. 12(4). 395–413. 17 indexed citations
11.
Fritz, Richard, Daniel Portsmouth, M. Keith Howard, et al.. (2013). Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population. The Journal of Infectious Diseases. 209(1). 12–23. 24 indexed citations
12.
Schwendinger, Michael G., Andreas Traweger, Helga Savidis-Dacho, et al.. (2013). Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model. PLoS ONE. 8(11). e79022–e79022. 9 indexed citations
13.
Sabarth, Nicolas, Helga Savidis-Dacho, Michael G. Schwendinger, et al.. (2012). A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination. Vaccine. 30(37). 5533–5540. 5 indexed citations
14.
Ehrlich, Hartmut J., Markus Müller, Herwig Kollaritsch, et al.. (2012). Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Vaccine. 30(30). 4543–4551. 14 indexed citations
15.
Ehrlich, Hartmut J., Júlia Singer, S. Fritsch, et al.. (2012). A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals. Clinical Infectious Diseases. 54(7). 946–954. 22 indexed citations
16.
17.
Howard, M. Keith, Nicolas Sabarth, Helga Savidis-Dacho, et al.. (2011). H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model. PLoS ONE. 6(8). e23791–e23791. 21 indexed citations
18.
Ehrlich, Hartmut J., Sandor Fritsch, Gerald Aichinger, et al.. (2011). Clinical development of a Vero cell culture-derived seasonal influenza vaccine. Vaccine. 30(29). 4377–4386. 21 indexed citations
19.
Aichinger, Gerald, Hartmut J. Ehrlich, John Aaskov, et al.. (2011). Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial. Vaccine. 29(50). 9376–9384. 1 indexed citations
20.
Barrett, Perry, et al.. (2010). Developing cell culture-derived pandemic vaccines.. PubMed. 12(1). 21–30. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abi George Aleyas Breakdown of academic impact, for papers by Karen M. van der Meulen Breakdown of academic impact, for papers by Maurício A. Martins Breakdown of academic impact, for papers by Brian E. Dawes Breakdown of academic impact, for papers by Huiyong Wei Breakdown of academic impact, for papers by Souichi Yamada Breakdown of academic impact, for papers by Kenn Forberg Breakdown of academic impact, for papers by Jianhua Le Breakdown of academic impact, for papers by Marina Escalera‐Zamudio Breakdown of academic impact, for papers by Drishya Kurup
Rankless by CCL
2026